CA2466657A1 - Systeme de liberation prolongee de medicaments solubles - Google Patents
Systeme de liberation prolongee de medicaments solubles Download PDFInfo
- Publication number
- CA2466657A1 CA2466657A1 CA002466657A CA2466657A CA2466657A1 CA 2466657 A1 CA2466657 A1 CA 2466657A1 CA 002466657 A CA002466657 A CA 002466657A CA 2466657 A CA2466657 A CA 2466657A CA 2466657 A1 CA2466657 A1 CA 2466657A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical formulation
- sustained release
- oral sustained
- release pharmaceutical
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
Abstract
L'invention se rapporte à de nouvelles préparations orales à libération prolongée afin d'administrer un agent actif (par exemple un médicament), notamment un médicament fortement hydrosoluble. Plus précisément, cette invention porte sur de nouvelles préparations contenant un médicament à formation de micelles présentant une charge et au moins un polymère possédant une charge opposée. L'invention concerne des procédés d'utilisation des nouvelles préparations.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US787701A | 2001-11-13 | 2001-11-13 | |
US10/007,877 | 2001-11-13 | ||
PCT/US2002/036681 WO2003041656A2 (fr) | 2001-11-13 | 2002-11-12 | Systeme de liberation prolongee de medicaments solubles |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2466657A1 true CA2466657A1 (fr) | 2003-05-22 |
CA2466657C CA2466657C (fr) | 2011-02-01 |
Family
ID=21728577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2466657A Expired - Fee Related CA2466657C (fr) | 2001-11-13 | 2002-11-12 | Systeme de liberation prolongee de medicaments solubles |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1443901A4 (fr) |
JP (2) | JP4882200B2 (fr) |
KR (2) | KR101016619B1 (fr) |
CN (1) | CN100534531C (fr) |
AU (1) | AU2002348279C1 (fr) |
CA (1) | CA2466657C (fr) |
MX (1) | MXPA04004544A (fr) |
PL (1) | PL374280A1 (fr) |
RU (1) | RU2322263C2 (fr) |
WO (1) | WO2003041656A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050042289A1 (en) * | 2003-04-29 | 2005-02-24 | Yamanouchi Pharma Technologies, Inc. | Tablets and methods for modified release of hydrophylic and other active agents |
JP4822092B2 (ja) * | 2003-09-01 | 2011-11-24 | 大正製薬株式会社 | W/o/w型複合エマルション |
US20060210625A1 (en) * | 2003-11-04 | 2006-09-21 | Shire Laboratories, Inc. | Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
US8197846B2 (en) * | 2003-11-10 | 2012-06-12 | Astellas Pharma Inc. | Sustained release pharmaceutical composition |
KR100638041B1 (ko) * | 2003-12-24 | 2006-10-23 | 주식회사 삼양사 | 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법 |
EP2412366A4 (fr) * | 2009-03-25 | 2013-08-07 | Lintec Corp | Préparation solide |
KR101319420B1 (ko) * | 2011-03-18 | 2013-10-17 | 한남대학교 산학협력단 | 서방형 방출이 가능한 수용성 양이온 약물 전달 시스템 |
EP2696853B1 (fr) * | 2011-04-11 | 2019-10-23 | Council of Scientific & Industrial Research | Dissociation de nano-containers induite en surface |
CN102977413B (zh) * | 2011-09-07 | 2015-05-13 | 江南大学 | 聚合物复合制备胶束的一种新方法 |
CN103083222B (zh) * | 2011-10-28 | 2015-08-19 | 江南大学 | 一锅法制备三组分聚合物胶束 |
JP6041823B2 (ja) | 2013-03-16 | 2016-12-14 | ファイザー・インク | トファシチニブの経口持続放出剤形 |
WO2022038409A1 (fr) * | 2020-08-19 | 2022-02-24 | 주식회사 모든바이오 | Nanoparticules comprenant de la glycyrrhizine et un médicament soluble dans l'eau, composition pharmaceutique les contenant, et leurs procédés de préparation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE32806B1 (en) * | 1968-05-21 | 1973-12-12 | American Home Prod | Sustained release drug composition |
JPS6410466A (en) * | 1987-07-01 | 1989-01-13 | Brother Ind Ltd | Data recording and reproducing method for magnetic disk |
US5219563A (en) * | 1988-05-11 | 1993-06-15 | Glaxo Group Limited | Drug adsorbates |
PL175026B1 (pl) * | 1992-09-18 | 1998-10-30 | Yamanouchi Pharma Co Ltd | Preparat typu hydrożelu o przedłużonym działaniu |
US5788959A (en) * | 1995-04-24 | 1998-08-04 | University Of Maryland, Baltimore County | Drug delivery device and method for employing the same |
CA2228610C (fr) * | 1995-08-17 | 2008-06-03 | Heidi Rolfes | Produits a liberation controlee |
IT1297461B1 (it) * | 1997-10-29 | 1999-12-17 | Ciocca Maurizio | Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili |
SK285478B6 (sk) * | 1998-09-14 | 2007-02-01 | Ranbaxy Laboratories Limited | Jednodenná formulácia na orálne podanie na kontrolované uvoľňovanie ciprofloxacínu |
US6287599B1 (en) * | 2000-12-20 | 2001-09-11 | Shire Laboratories, Inc. | Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles |
AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
-
2002
- 2002-11-12 RU RU2004117848/15A patent/RU2322263C2/ru not_active IP Right Cessation
- 2002-11-12 AU AU2002348279A patent/AU2002348279C1/en not_active Ceased
- 2002-11-12 WO PCT/US2002/036681 patent/WO2003041656A2/fr active Application Filing
- 2002-11-12 JP JP2003543543A patent/JP4882200B2/ja not_active Expired - Fee Related
- 2002-11-12 KR KR1020047007206A patent/KR101016619B1/ko not_active IP Right Cessation
- 2002-11-12 CN CNB028270355A patent/CN100534531C/zh not_active Expired - Fee Related
- 2002-11-12 PL PL02374280A patent/PL374280A1/xx not_active Application Discontinuation
- 2002-11-12 EP EP02782303A patent/EP1443901A4/fr not_active Ceased
- 2002-11-12 KR KR1020107024523A patent/KR101132969B1/ko not_active IP Right Cessation
- 2002-11-12 CA CA2466657A patent/CA2466657C/fr not_active Expired - Fee Related
- 2002-11-12 MX MXPA04004544A patent/MXPA04004544A/es active IP Right Grant
-
2011
- 2011-01-12 JP JP2011004215A patent/JP4894958B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1443901A2 (fr) | 2004-08-11 |
CN100534531C (zh) | 2009-09-02 |
JP2005508995A (ja) | 2005-04-07 |
KR20050044424A (ko) | 2005-05-12 |
KR20100123779A (ko) | 2010-11-24 |
JP4882200B2 (ja) | 2012-02-22 |
KR101132969B1 (ko) | 2012-04-09 |
AU2002348279B2 (en) | 2008-01-24 |
KR101016619B1 (ko) | 2011-02-23 |
CA2466657C (fr) | 2011-02-01 |
JP2011068700A (ja) | 2011-04-07 |
CN1612726A (zh) | 2005-05-04 |
EP1443901A4 (fr) | 2010-06-16 |
WO2003041656A2 (fr) | 2003-05-22 |
MXPA04004544A (es) | 2005-03-31 |
RU2004117848A (ru) | 2005-05-27 |
RU2322263C2 (ru) | 2008-04-20 |
JP4894958B2 (ja) | 2012-03-14 |
PL374280A1 (en) | 2005-10-03 |
WO2003041656A3 (fr) | 2003-10-23 |
AU2002348279C1 (en) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0460020B2 (fr) | Compositions pour l'administration de medicaments | |
EP0739197B1 (fr) | Conservation de compositions de medicaments ophtalmiques contenant des composes d'ammonium quaternaire polymere | |
RU2108112C1 (ru) | Водная лекарственная композиция, обладающая свойством обратимого терморегулируемого гелеобразования | |
US5744166A (en) | Drug delivery compositions | |
EP0792147B1 (fr) | Composition pharmaceutique contenant des medicaments antiinflammatoires non steroidiens | |
US6251430B1 (en) | Water insoluble polymer based sustained release formulation | |
EP1722759B1 (fr) | Composition contenant du chitosane et un phosphate de sucre ou un phosphate de polyol | |
US6159491A (en) | Prolonged release bioadhesive vaginal gel dosage form | |
JP4728580B2 (ja) | 製剤 | |
US8349363B2 (en) | Temperature responsive delivery systems | |
ES2396598T3 (es) | Preparaciones en forma de suspensiones acuosas | |
CA2466657A1 (fr) | Systeme de liberation prolongee de medicaments solubles | |
US8653055B2 (en) | Corticosteroid having low systemic absorption | |
TWI336257B (en) | Ophthalmic compositions containing a synergistic combination of three polymers | |
CA2433186A1 (fr) | Preparations pharmaceutiques a liberation retardee | |
Fini et al. | The role of chitosan in drug delivery: current and potential applications | |
WO2009066146A2 (fr) | Solutions stables d'actifs solubles de façon restreinte | |
EP0944383A1 (fr) | Systemes pharmaceutiques de suspensions | |
CN102724965B (zh) | 含羧乙烯基聚合物的纳米颗粒混悬液 | |
WO1995004527A1 (fr) | Capsules de gelatine contenant une solution d'acetaminophene fortement concentree | |
PL187764B1 (pl) | Tabletki farmaceutyczne o kontrolowanym uwalnianiu zawierające nośnik oparty na sieciowanej amylozie i hydroksypropylometylocelulozie oraz zastosowanie hydroksypropylometylocelulozy | |
JP2011132259A (ja) | コンタクトレンズでの使用に適する眼の抗アレルギー組成物 | |
WO2010041279A3 (fr) | Système d'administration de médicaments à libération prolongée | |
JP4268227B2 (ja) | 固体粒子形成用組成物 | |
CN1897917A (zh) | 局部眼部应用的氯替泼诺和妥布霉素混悬剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20151112 |